Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myometrial muscle cell membrane stabilization describes the process by which ionic homeostasis and the activity of ion channels (notably BKCa, SLO2.1, NALCN, and gap junctions) maintain the proper electrical polarization of uterine smooth muscle cells, ensuring uterine quiescence in pregnancy and enabling coordinated contractions at term. This process is tightly regulated by hormonal signals such as oxytocin, and by cellular mechanisms controlling ion channel function, membrane potential, and cell-to-cell coupling. It is essential for successful pregnancy and parturition, but does not describe a distinct, targetable biomolecule or receptor.
Ion channel modulation (eg, activation of BKCa channels induces relaxation; inhibition leads to increased contractility). Oxytocin binds to its receptor, activating intracellular signaling to depolarize the membrane and promote contraction. Gap junction modulators (increase electrical coupling, synchronizing contractions).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myometrial muscle cell membrane stabilization.